Nephro Care Complete Financial Statements
In FY2026, Nephro Care (NEPHROCARE) reported revenue ₹28 Cr, net profit ₹1 Cr and EPS ₹0.61, with a net profit margin of 3.6% and ROE of 1.8%. Full financial statements from FY2020 to FY2026 (7 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
NEPHROCARE Revenue, Net Profit & EBITDA — Year-on-Year Growth
NEPHROCARE YoY (Jun 2025 vs Mar 2026) — revenue +64.7%, net profit +200.0%, EBITDA +200.0%, expenses +47.1%. Compare with Nephro Care value estimation to assess whether the stock is under or overvalued.
NEPHROCARE Income Statement — Revenue, EBITDA & Net Profit
Nephro Care revenue ₹28 Cr, EBITDA ₹3 Cr, net profit ₹1 Cr, EPS ₹0.61 (2026) — net profit margin 3.6%. For live price, earnings ratios and company overview, see NEPHROCARE share price screener.
| Particulars | Mar 2026 | Jun 2026 | Jun 2025 |
|---|---|---|---|
| Revenue | 28 | 29 | 17 |
| Expenses | 25 | 26 | 17 |
| EBITDA | 3 | 4 | 1 |
| Operating Profit Margin % | 8.00% | 12.00% | 3.00% |
| Depreciation | 2 | 1 | 1 |
| Interest | 0 | 0 | 0 |
| Profit Before Tax | 1 | 3 | -1 |
| Tax | 0 | 1 | 0 |
| Net Profit | 1 | 2 | -1 |
| Earnings Per Share (₹) | 0.61 | 0.98 | -0.39 |
NEPHROCARE Balance Sheet — Assets, Liabilities & Shareholders' Equity
NEPHROCARE total assets ₹73 Cr, total equity ₹57 Cr, total liabilities ₹ Cr (2026) — ROE 1.8%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Total Assets | 73 | 68 | 21 | 8 | 5 | 1 | 1 |
| Current Assets | 31 | 28 | 11 | 3 | 1 | 1 | 0 |
| Fixed Assets | 35 | 32 | 5 | 3 | 1 | 1 | 1 |
| Capital Work in Progress | 0 | 1 | 1 | 0 | 2 | 0 | 0 |
| Investments | 2 | 16 | 7 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 20 | 9 | 5 | 1 | 1 | 0 |
| LIABILITIES | |||||||
| Total Liabilities | |||||||
| Current Liabilities | 1 | 1 | 0 | 2 | 3 | 1 | 0 |
| Non-Current Liabilities | |||||||
| SHAREHOLDERS' EQUITY | |||||||
| Total Equity | 57 | 54 | 15 | 3 | 1 | 0 | 0 |
| Share Capital | 17 | 17 | 12 | 1 | 1 | 0 | 0 |
| Reserves & Surplus | 40 | 37 | 3 | 2 | 0 | 0 | 0 |
NEPHROCARE Cash Flow Statement — Operating, Investing & Financing
Nephro Care operating cash flow ₹8 Cr, investing ₹-40 Cr, financing ₹35 Cr, net cash flow ₹3 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|
| Operating Activities | 8 | 1 | 4 | 1 | 0 |
| Investing Activities | -40 | -8 | -2 | -3 | 0 |
| Financing Activities | 35 | 6 | 0 | 2 | 0 |
| Net Cash Flow | 3 | -1 | 2 | 0 | 0 |